 |
|
|
| |
Highly Effective Two-drug Regimens of an Integrase Inhibitor and Reverse Transcriptase Inhibitor in Real-World Setting - Data from COMBINE-2 Study
|
| |
| |
EACS 2021 Oct 27-30
Cristina Mussini,1 Cassidy Henegar,2 Lambert Assoumou,3 Stephane De Wit,4 Margaret Johnson,5 Eugenia Quiros Roldan,6 Leigh Ragone,2 Jean van Wyk,7 Michael Aboud,7
Carl Fletcher,8 Annie Duffy,8 Anton Pozniak,3 Vani Vannappagari 2 on behalf of the COMBINE-2 Study Group
1University of Modena and Reggio Emilia, Policlinico Hospital, Infectious Diseases Clinic, Modena, Italy; 2ViiV Healthcare, RTP, US; 3 The European treatment network for HIV, hepatitis and global infectious diseases (NEAT-ID), London, UK; 4Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium, 5Royal Free Hospital, London, UK; 6 University of Brescia, Brescia, Italy; 7ViiV Healthcare, Brentford, Middlesex, UK; 8Research Organization (KC) Ltd., London, UK;
|
| |
|
|
|
|
|
